Tim HainesExecutive Partner at AbingworthSpeaker
Agenda Sessions
Life Science Executives in 2024: Evaluating a Critical Year of Shifting Approvals, Rejuvenated Funding, and Strategic Deals for Future Success
, 09:35View Session